Balakumar Vijayakrishnan
Director - Bioconjugation & Analytical AstraZeneca
Balakumar Vijayakrishnan is a chemical Biologist with expertise in ADCs (Antibody Drug Conjugates) pipeline, platform and linker development. Special focus on Bioconjugation technologies for ADCs and related scaffolds, purification, characterisation and in vitro stability assessment. Experienced in oligosaccharide synthesis, Chemo-enzymatic site selective protein modifications, protein purification, in vitro enzyme assays, biophysical characterization, stakeholder, people and project management.
Seminars
Tuesday 24th February 2026
Expanding the Frontiers of ADC Biophysical Characterisation: Enhancing Analytical Strategies for Candidate Selection
12:00 pm
- Examining the analytical assay needs for ADCs from a stability perspective
- Demonstrating how in vitro assay results guide the rational selection of ADC candidates for further development
- Evaluating emerging opportunities to automate biophysical characterisation ADC workflows
